The published VERITON and D-SPECT range set out configuration by configuration, what the move from sodium iodide to CZT actually changes clinically, and the licensing and cost-of-ownership questions a Bangladeshi hospital has to answer first.
Nuclear medicine in Bangladesh is at an inflection point. The country has over 30 licensed nuclear medicine centres, operated by the Bangladesh Atomic Energy Commission (BAEC), by government medical colleges and by a growing number of private hospitals. Demand for functional imaging in cardiac disease, oncology and thyroid disorders is rising quickly. The technology available to most of those centres, though, is a generation behind what is now standard in Singapore, India and South Korea. Spectrum Dynamics Medical (USA) has changed what a SPECT department can do with its VERITON and D-SPECT platforms, and Vvon Technologies is its authorised partner in Bangladesh. This is what the range consists of, and how to work out which part of it you are actually buying.
Conventional gamma cameras use sodium iodide (NaI) scintillator crystals coupled to photomultiplier tubes, a design that has been largely unchanged since the 1970s. NaI detectors are large and fragile, their photomultiplier gain drifts with temperature and has to be retuned, and their energy resolution is limited. The VERITON platform uses cadmium zinc telluride (CZT) solid-state detectors, which removes the photomultiplier tube entirely. CZT converts gamma photons directly to an electrical signal, giving considerably better energy resolution, higher sensitivity and a far more compact detector geometry.
| Parameter | Conventional NaI gamma camera | Spectrum Dynamics VERITON (CZT) |
|---|---|---|
| Energy resolution | About 9 to 10% FWHM at 140 keV | About 5.5% FWHM at 140 keV on the earlier VERITON ring and about 3.2% on the current VERITON-CT 400 Series, against 9 to 10% for sodium iodide, so roughly 40 to 60% better |
| Sensitivity | Baseline | Up to 8x higher sensitivity for cardiac SPECT |
| Scan time (cardiac) | 15 to 20 minutes | 2 to 4 minutes, so higher patient throughput |
| Radiation dose | Standard | Up to 50% dose reduction possible |
| Detector geometry | Large rotating gantry | Compact stationary multi-detector array |
| Uptime | Mechanical gantry rotation required | No moving parts in the detector, higher reliability |
The energy resolution figure is the one to hold onto, because it is upstream of everything else. Better energy resolution means scatter is rejected more effectively, which means a cleaner image at the same counts, which is what lets a department trade the improvement for either a shorter scan or a lower administered dose. Sensitivity and scan time are consequences, not independent benefits.
The VERITON is the SPECT-only member of the family. Twelve digital CZT detector columns sit in a 360 degree ring-shaped gantry, and the columns swivel to acquire data during the scan while each detector contours adaptively to the patient's body. Reconstruction runs OSEM iterative with resolution recovery, attenuation correction and scatter correction. This is the configuration for a department that wants CZT performance and does not need diagnostic CT in the same room.
The VERITON-CT 400 Series is the hybrid system: the same ring of 12 swivelling CZT detector columns, which move to within millimetres of the body contour, combined with a diagnostic CT. The bore is 80 cm for both the nuclear medicine and the CT sections, the hybrid scan range is 200 cm with real-time body contouring, so it images head to toes in a single hybrid pass, and CT coverage runs up to 20 or 40 mm at 0.625 mm spatial resolution. The platform is FDA cleared, CE marked and Health Canada approved.
The CT sub-system is a specification line in its own right, and it is set at order rather than afterwards. The decision is not about the SPECT performance, which does not change, it is about what you want the CT to do. If the CT exists to provide attenuation correction and anatomical localisation for the SPECT study, the shorter detector coverage is sufficient and cheaper to run. If the department intends to use the CT as a diagnostic scanner in its own right, for cardiac work or for a hospital that does not have a separate CT, specify the wider coverage. Ask Spectrum Dynamics for the current configuration options in writing at tender stage, because deciding this after installation is not possible.
The dedicated cardiac line, and a genuinely different machine rather than a cut-down VERITON. D-SPECT CARDIO has an open gantry with 6 or 9 CZT detector columns that swivel while the gantry itself stays still. The patient can be scanned upright, supine or at any angle in between, the chair supports up to 454 kg, a myocardial perfusion scan can be as fast as two minutes, and list mode acquisition with a 20 second pre-scan scout supports quantification such as coronary flow reserve. D-SPECT VISTA is the entry point for a department moving off an analogue sodium iodide cardiac camera: the same flexible positioning, optional TruCorr Attenuation Correction derived from the patient's own SPECT emission data rather than a CT or Gd-153 transmission scan, and an upgrade path to CARDIO when dynamic applications are needed.
The VERITON series runs the TruView Console, which holds acquisition, quantitative reconstruction and review in one place, manages hybrid, SPECT and stand-alone CT protocols, and offers optional dosimetry, SIRT planning and brain SPECT tools on a vendor-neutral platform. The D-SPECT series runs the TruSPECT Workstation. Around those sit TruCorr Attenuation Correction, a deep learning method that works from the patient's own emission data in a single acquisition; Veritas.AI, deep learning noise reduction for the VERITON-CT 400 Series that preserves resolution and quantitative integrity while cutting noise, for which Spectrum Dynamics announced FDA 510(k) clearance in January 2026; TruClear.AI Noise Reduction for low-count D-SPECT acquisitions; and TruFlow Dynamic Imaging for dynamic SPECT including myocardial blood flow.
| Clinical application | What CZT changes | Bangladesh relevance |
|---|---|---|
| Cardiac SPECT (MPI) | 8x sensitivity, 2 to 4 minute scan, half-dose protocols | Ischaemic heart disease is Bangladesh's leading cause of death, so fast, low-dose cardiac imaging matters at population scale |
| Oncology (bone, lung, liver, kidney) | Higher resolution, faster scan, better lesion detection | Cancer incidence is rising, and earlier detection improves outcomes and reduces treatment cost |
| Thyroid (I-123 and I-131) | Superior energy resolution separates I-123 from I-131 scatter | Thyroid disorders are highly prevalent here |
| Neurology (DaTscan, brain perfusion) | High resolution supports confident differentiation in Parkinsonian syndromes | Growing demand as neurological diagnosis improves |
| Paediatric imaging | Lower dose and faster scan reduce the need for sedation | Paediatric nuclear medicine is underserved |
All nuclear medicine equipment in Bangladesh requires authorisation from BAERA, the Bangladesh Atomic Energy Regulatory Authority, which is the national regulator rather than the Atomic Energy Commission. The VERITON-CT 400 Series is a registered medical device in the USA under FDA 510(k) and in the European Union under CE marking, which simplifies the BAERA technical review because the dossier the reviewer needs already exists. Vvon Technologies supports our hospital clients through the licensing process, from initial facility design review through to commissioning certificate, with the application made in the hospital's name.
What the hospital cannot delegate is the building. A ring-gantry hybrid system has floor loading, door and route, power and cooling requirements that have to be checked against the actual room before the order, and a hot lab and waste route that have to be designed into the layout rather than fitted around it. Those checks take a day. Discovering the problem after shipping takes months.
The higher acquisition cost of a CZT platform against a conventional gamma camera is offset by lower operating costs and higher revenue potential. The drivers are patient throughput, where a 2 to 4 minute cardiac scan against 15 to 20 minutes allows three to five times more patients per day; radiopharmaceutical cost, where dose reduction protocols cut Tc-99m consumption on a recurring basis; maintenance cost, with no photomultiplier tubes to replace and no mechanical gantry rotation to service; and pricing, where digital SPECT/CT supports higher fees from insurers and self-pay patients. Payback depends on the capital base and the case mix rather than on the camera alone. A complete department, including shielding, hot lab, dose calibrator and licensing, is a far larger number than the camera, and what the payback on a nuclear medicine department actually depends on works through where a given hospital lands inside that band.
That last figure carries an assumption worth stating plainly: it assumes the referrals exist to fill 10 cardiac studies a day. Throughput is only worth paying for if the list is full. A department doing 30 cardiac studies a month will not recover a CZT premium through speed, and would be better served by a conventional dual-head camera and a longer scan time. The honest test is not whether CZT is better. It is whether your cardiology service can keep it busy.